Baidu
map

政策与人文

订阅

MedSci主页 / 所有栏目 / 政策与人文

重磅：卫计委公布首批干细胞临床研究机构备案名单

2016-05-30 佚名 卫计委

干细胞临床研究
关注

5月30日，国家卫计委发布了关于首批干细胞临床研究机构备案的公示，公示显示，按照《干细胞临床研究管理办法（试行）》要求，国家干细胞临床研究专家委员会对各地报送的干细胞临床研究机构备案材料进行了审核，根据专家委员会意见，形成了干细胞临床研究机构首批通过备案的建议名单（见附件）。 从即日起至2016年6月8日对拟备案机构进行公示。如有异议，请通过以下联系方式实名反映。 联系人：国家卫生计生委科教司

5月30日，国家卫计委发布了关于首批干细胞临床研究机构备案的公示，公示显示，按照《干细胞临床研究管理办法（试行）》要求，国家干细胞临床研究专家委员会对各地报送的干细胞临床研究机构备案材料进行了审核，根据专家委员会意见，形成了干细胞临床研究机构首批通过备案的建议名单（见附件）。

从即日起至2016年6月8日对拟备案机构进行公示。如有异议，请通过以下联系方式实名反映。

联系人：国家卫生计生委科教司   尹旭珂 王锦倩

电话：010-68792955  邮箱：nhfpcsc@126.com

通讯地址：北京市西城区西直门外南路1号

邮编：100044

联系人：食品药品监管总局药化注册司 常卫红

电话：010-88330713   邮箱：changwh@sda.gov.cn

通讯地址：北京市西城区宣武门西大街26号院2号楼

邮编：100053

附干细胞临床研究机构首批通过备案名单

（生物谷 Bioon.com）

 

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1935384, encodeId=5eb419353846c, content=<a href='/topic/show?id=44dce341015' target=_blank style='color:#2F92EE;'>#研究机构#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73410, encryptionId=44dce341015, topicName=研究机构)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIibticIBly5jCSic5ZElW4He3rO4DMpUHUFaFX57OicNMnzckWaicBNeStwugWHFCuOdicoakApM4HGmtw/132, createdBy=f8672500006, createdName=ms6390871039024434, createdTime=Mon Oct 10 09:12:00 CST 2016, time=2016-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1354042, encodeId=44791354042f2, content=<a href='/topic/show?id=4d723669096' target=_blank style='color:#2F92EE;'>#卫计委#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36690, encryptionId=4d723669096, topicName=卫计委)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Wed Jun 01 11:12:00 CST 2016, time=2016-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1548842, encodeId=12f1154884251, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96000, encryptionId=f7879600061, topicName=重磅)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3acc14121561, createdName=xxxx1054, createdTime=Wed Jun 01 11:12:00 CST 2016, time=2016-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1590894, encodeId=7ff11590894f9, content=<a href='/topic/show?id=f175424e6fe' target=_blank style='color:#2F92EE;'>#备案#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42476, encryptionId=f175424e6fe, topicName=备案)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=41f217885803, createdName=cenghis, createdTime=Wed Jun 01 11:12:00 CST 2016, time=2016-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=87905, encodeId=90c48e905e9, content=有没有我们单位, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cache2.medsci.cn//images/medsci_toux.jpg, createdBy=7af91730839, createdName=足球疯子, createdTime=Tue May 31 21:06:00 CST 2016, time=2016-05-31, status=1, ipAttribution=)]
    2016-10-10 ms6390871039024434

    #研究机构#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1935384, encodeId=5eb419353846c, content=<a href='/topic/show?id=44dce341015' target=_blank style='color:#2F92EE;'>#研究机构#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73410, encryptionId=44dce341015, topicName=研究机构)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIibticIBly5jCSic5ZElW4He3rO4DMpUHUFaFX57OicNMnzckWaicBNeStwugWHFCuOdicoakApM4HGmtw/132, createdBy=f8672500006, createdName=ms6390871039024434, createdTime=Mon Oct 10 09:12:00 CST 2016, time=2016-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1354042, encodeId=44791354042f2, content=<a href='/topic/show?id=4d723669096' target=_blank style='color:#2F92EE;'>#卫计委#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36690, encryptionId=4d723669096, topicName=卫计委)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Wed Jun 01 11:12:00 CST 2016, time=2016-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1548842, encodeId=12f1154884251, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96000, encryptionId=f7879600061, topicName=重磅)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3acc14121561, createdName=xxxx1054, createdTime=Wed Jun 01 11:12:00 CST 2016, time=2016-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1590894, encodeId=7ff11590894f9, content=<a href='/topic/show?id=f175424e6fe' target=_blank style='color:#2F92EE;'>#备案#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42476, encryptionId=f175424e6fe, topicName=备案)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=41f217885803, createdName=cenghis, createdTime=Wed Jun 01 11:12:00 CST 2016, time=2016-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=87905, encodeId=90c48e905e9, content=有没有我们单位, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cache2.medsci.cn//images/medsci_toux.jpg, createdBy=7af91730839, createdName=足球疯子, createdTime=Tue May 31 21:06:00 CST 2016, time=2016-05-31, status=1, ipAttribution=)]
    2016-06-01 zhaojie88

    #卫计委#

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1935384, encodeId=5eb419353846c, content=<a href='/topic/show?id=44dce341015' target=_blank style='color:#2F92EE;'>#研究机构#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73410, encryptionId=44dce341015, topicName=研究机构)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIibticIBly5jCSic5ZElW4He3rO4DMpUHUFaFX57OicNMnzckWaicBNeStwugWHFCuOdicoakApM4HGmtw/132, createdBy=f8672500006, createdName=ms6390871039024434, createdTime=Mon Oct 10 09:12:00 CST 2016, time=2016-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1354042, encodeId=44791354042f2, content=<a href='/topic/show?id=4d723669096' target=_blank style='color:#2F92EE;'>#卫计委#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36690, encryptionId=4d723669096, topicName=卫计委)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Wed Jun 01 11:12:00 CST 2016, time=2016-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1548842, encodeId=12f1154884251, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96000, encryptionId=f7879600061, topicName=重磅)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3acc14121561, createdName=xxxx1054, createdTime=Wed Jun 01 11:12:00 CST 2016, time=2016-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1590894, encodeId=7ff11590894f9, content=<a href='/topic/show?id=f175424e6fe' target=_blank style='color:#2F92EE;'>#备案#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42476, encryptionId=f175424e6fe, topicName=备案)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=41f217885803, createdName=cenghis, createdTime=Wed Jun 01 11:12:00 CST 2016, time=2016-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=87905, encodeId=90c48e905e9, content=有没有我们单位, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cache2.medsci.cn//images/medsci_toux.jpg, createdBy=7af91730839, createdName=足球疯子, createdTime=Tue May 31 21:06:00 CST 2016, time=2016-05-31, status=1, ipAttribution=)]
    2016-06-01 xxxx1054

    #重磅#

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1935384, encodeId=5eb419353846c, content=<a href='/topic/show?id=44dce341015' target=_blank style='color:#2F92EE;'>#研究机构#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73410, encryptionId=44dce341015, topicName=研究机构)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIibticIBly5jCSic5ZElW4He3rO4DMpUHUFaFX57OicNMnzckWaicBNeStwugWHFCuOdicoakApM4HGmtw/132, createdBy=f8672500006, createdName=ms6390871039024434, createdTime=Mon Oct 10 09:12:00 CST 2016, time=2016-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1354042, encodeId=44791354042f2, content=<a href='/topic/show?id=4d723669096' target=_blank style='color:#2F92EE;'>#卫计委#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36690, encryptionId=4d723669096, topicName=卫计委)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Wed Jun 01 11:12:00 CST 2016, time=2016-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1548842, encodeId=12f1154884251, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96000, encryptionId=f7879600061, topicName=重磅)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3acc14121561, createdName=xxxx1054, createdTime=Wed Jun 01 11:12:00 CST 2016, time=2016-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1590894, encodeId=7ff11590894f9, content=<a href='/topic/show?id=f175424e6fe' target=_blank style='color:#2F92EE;'>#备案#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42476, encryptionId=f175424e6fe, topicName=备案)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=41f217885803, createdName=cenghis, createdTime=Wed Jun 01 11:12:00 CST 2016, time=2016-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=87905, encodeId=90c48e905e9, content=有没有我们单位, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cache2.medsci.cn//images/medsci_toux.jpg, createdBy=7af91730839, createdName=足球疯子, createdTime=Tue May 31 21:06:00 CST 2016, time=2016-05-31, status=1, ipAttribution=)]
    2016-06-01 cenghis

    #备案#

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1935384, encodeId=5eb419353846c, content=<a href='/topic/show?id=44dce341015' target=_blank style='color:#2F92EE;'>#研究机构#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73410, encryptionId=44dce341015, topicName=研究机构)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIibticIBly5jCSic5ZElW4He3rO4DMpUHUFaFX57OicNMnzckWaicBNeStwugWHFCuOdicoakApM4HGmtw/132, createdBy=f8672500006, createdName=ms6390871039024434, createdTime=Mon Oct 10 09:12:00 CST 2016, time=2016-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1354042, encodeId=44791354042f2, content=<a href='/topic/show?id=4d723669096' target=_blank style='color:#2F92EE;'>#卫计委#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36690, encryptionId=4d723669096, topicName=卫计委)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Wed Jun 01 11:12:00 CST 2016, time=2016-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1548842, encodeId=12f1154884251, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96000, encryptionId=f7879600061, topicName=重磅)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3acc14121561, createdName=xxxx1054, createdTime=Wed Jun 01 11:12:00 CST 2016, time=2016-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1590894, encodeId=7ff11590894f9, content=<a href='/topic/show?id=f175424e6fe' target=_blank style='color:#2F92EE;'>#备案#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42476, encryptionId=f175424e6fe, topicName=备案)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=41f217885803, createdName=cenghis, createdTime=Wed Jun 01 11:12:00 CST 2016, time=2016-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=87905, encodeId=90c48e905e9, content=有没有我们单位, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cache2.medsci.cn//images/medsci_toux.jpg, createdBy=7af91730839, createdName=足球疯子, createdTime=Tue May 31 21:06:00 CST 2016, time=2016-05-31, status=1, ipAttribution=)]
    2016-05-31 足球疯子

    有没有我们单位

    0

相关资讯

关于成立国家干细胞临床研究专家委员会的通知

国卫办科教函〔2016〕324号 各省、自治区、直辖市卫生计生委、食品药品监管局，新疆生产建设兵团卫生局、食品药品监管局： 根据《干细胞临床研究管理办法（试行）》（国卫科教发〔2015〕48号）要求，国家卫生计生委与食品药品监管总局共同成立由干细胞基础及临床相关专业、干细胞制剂制备和质量控制等领域33位专家组成的国家干细胞临床研究专家委员会，为干细胞临床研究规范管理提供技术支撑。干细胞临床研究

JAAOS：评述用于治疗脊髓损伤的干细胞益处

干细胞疗法是一种快速演变的大有希望的脊髓损伤治疗方法。根据一篇新的发表在Journal of the American Academy of Orthopedic Surgeons（JAAOS）期刊上标题为“The Use of Cell Transplantation in Spinal Cord Injuries”的文献综述，不同类型的干细胞在恢复受损脊髓功能上存在差异，然而目前仍然没有

盘点：生物谷推荐：5月必看的重磅级研究

5月转眼就快要过去了，这个月又有哪些研究值得我们深读一下呢？小编将根据本月新闻的点击量、研究领域、热度筛选出了5月份值得一看的突破性研究。 【1】Science Cell子刊：丁胜突破性成果！利用特殊药物将皮肤细胞成功转化为心脏和大脑细胞 doi：10.1126/science.aaf1502 近日，来自格莱斯顿研究所（Gladstone Institutes）的科学家们利用一种组合

艺术家正用3D打印支架和干细胞长出一只人手

多年来，新媒体艺术家Amy Karle一直致力于通过衍生艺术来探索人体与技术之间的关系。她最近进行的一个被称为“再生圣物（Regenerative Reliquary）”的项目就继续着这种探索。在这个项目中她特别关注的是身体和人类细胞如何通过创造一只人手而在人体之外保持存活。这个让人惊悚的“再生圣物”，目前正在展出欧特克的创新孵化器——Pier 9——里面展示，该作品包括一个设计复杂的3D打印手形

SCRT：胎盘间充质干细胞治疗缺血性疾病又有新发现

近日，国家干细胞工程技术研究中心主任韩忠朝团队发表在Stem Cell Research & Therapy上的一篇题为《VCAM-1+胎盘绒毛膜间充质干细胞显示出强有力促血管生成活性》的文章受到国内外相关领域的高度关注。该文章阐述了血管细胞黏附分子-1+（VCAM-1+）胎盘绒毛膜间充质干细胞（CV-MSC）具有良好的促血管生成活性，成为理论走向临床治疗的重要一步。 许多研究已经证

干细胞研究新指南发布：旨在减轻伦理压力

在多个领域出现戏剧性进展，特别是操控人类胚胎的研究取得重要突破之后，代表干细胞科学家的一个国际学会日前更新了其研究指南。

Baidu
map
Baidu
map
Baidu
map